USP and Public Policy

usp public policy
Left
usp public policy

Refine Your Search

All Results
USP Global Public Policy Position: Fostering the Use of Novel Excipients in Drug Products
USP Global Public Policy Position: Fostering the Use of Novel Excipients in Drug Products; Published 2024. Learn More
USP Global Policy Position: Excipients: A Blind Spot in Ensuring Medicine Quality and Supply Chain Resilience
USP Global Policy Position: Excipients: A Blind Spot in Ensuring Medicine Quality and Supply Chain Resilience; Published 2024 Learn More
USP Comment Letter to CMS: Response to Proposed Rule on Drug Classification in Electronic Health Benefits (2024)
USP Comment Letter submitted to Centers for Medicare & Medicaid Services (CMS) in response to the proposed rule “Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment… Learn More

Document Classification

Topics